InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,551.20
(
-0.35%
)
Dow Jones
38,884.26
(
0.00%
)
Brent Oil
81.98
(
-1.07%
)
Bitcoin
62,322.57
(
-0.02%
)
Post# of 689602
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

extrooper

Send PM Follow Ignore
Followers 20
Posts 1931
Boards Moderated 0
Alias Born 08/29/2018

extrooper

Re: iclight post# 681640

Wednesday, 03/27/2024 3:03:58 PM

Wednesday, March 27, 2024 3:03:58 PM

Post# of 689602
The difference is, DCVax-L is actually a great therapy that helps extend patient lives with virtually no side affects. It has also completed all clinical and is considered by most reputable scientists and doctors to be an excellent therapy . DCVax is also considered to be a platform biologic for other therapies to be more successful and enduring.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Start posting your company's news
Only $200 per official company press release!